SavedAdd your journal

Journals / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 9

The neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and mean platelet volume in patients with chronic otitis media and cholesteatoma

Cengiz ÇELİKYURT
Erdal SAKALLI
Dastan TEMİRBEKOV
Emre TÜRKMEN
Pages
2002–2005
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although inflammationplays an important role in cholesteatoma pathogenesis, any effect thereof is local rather than systemic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume (MPV) are widely usedsimple markers of subclinical inflammation.
📊
Key Findings & Data:We explored whether these parameters were affected in patients with chronic otitismedia (COM) with and without cholesteatoma.Material and Methods: We studied 295 COM patients operated upon in our hospital and 135 healthy subjects were devoid ofinflammation (controls).
💡
Conclusion & Impact:Although inflammationplays an important role in cholesteatoma pathogenesis, any effect thereof is local rather than systemic.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume (MPV) are widely usedsimple markers of subclinical inflammation. We explored whether these parameters were affected in patients with chronic otitismedia (COM) with and without cholesteatoma.Material and Methods: We studied 295 COM patients operated upon in our hospital and 135 healthy subjects were devoid ofinflammation (controls). The patients were divided into two groups depending on cholesteatoma status: COM with cholesteatoma(the COMch group) and COM without cholesteatoma (the COM group). The groups were compared in terms of their NLRs, PLRs, andMPVs. The NLR and PLR were calculated by dividing the numbers of neutrophils and platelets by that of lymphocytes.Results: Of the 295 patients, 149 and 146 had COMch and COM, respectively. No significant difference (P 0.05) was evident in anyof NLR, PLR, or MPV between the study groups.Conclusion: None of LNR, PLR, or MPV differed significantly in COM patients with and without cholesteatoma. Although inflammationplays an important role in cholesteatoma pathogenesis, any effect thereof is local rather than systemic.

🔖

Cite This Article

ÇELİKYURT, C., SAKALLI, E., TEMİRBEKOV, D., TÜRKMEN, E. (2022). The neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and mean platelet volume in patients with chronic otitis media and cholesteatoma. Annals of Medical Research, Cilt: 26 - Sayı: 9, 2002–2005. https://ajindex.com/articles/446722

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Chirwa M, Mulwafu W, Aswani JM, et al. Microbiology of chronic suppurative otitis media at Queen Elizabeth Central Hospital, Blantyre, Malawi: A cross-sectional descriptive study. Malawi Med J 2015;27:120-4
  2. Hamed MA, Nakata S, Sayed RH, et al. Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives. Clin Exp Otorhinolaryngol. 2016;9:298-308
  3. Gaillardin L, Lescanne E, Moriniere S, et al. Residual cholesteatoma: prevalence and location. Follow-up strategy in adults. Eur Ann Otorhinolaryngol Head Neck Dis 2012;129:136–40
  4. Akkari M, Gabrillargues J, Saroul N, et al. Contribution of magnetic resonance imaging to the diagnosis of middle ear cholesteatoma: analysis of a series of 97 cases. Eur Ann Otorhinolaryngol Head Neck Dis 2014;131:153-8
  5. Ho SY, Kveton JF. Efficacy of the 2-staged procedure in the management of cholesteatoma. Arch Otolaryngol Head Neck Surg 2003;129:541-5
  6. Kum RO, Ozcan M, Baklaci D, Yurtsever KN, Yilmaz YF, Unal A, et al. Investigation of neutrophil-to-lymphocyte ratio and mean platelet volume in sudden hearing loss. Braz J Otorhinolaryngol 2015;81:636-41
  7. Ozler GS, Gunak G. Neutrophil–lymphocyte ratio: a new predictive and prognostic factor in patients with Bell palsy. J Craniofac Surg 2014;25:944–5
  8. Atan D, Apaydin E, Ozcan KM, et al. New diagnostic indicators in chronic otitis media with effusion: neutrophil to lymphocyte ratio and thrombocyte lymphocyte ratio. ENT Updates 2016;6:12-5
  9. Vaid S, Kamble Y, Vaid N, et al. Role of magnetic resonance imaging in cholesteatoma: the Indian experience. Indian J Otolaryngol Head Neck Surg 2013;65:485-92
  10. Pauna HF, Monsanto RC, Schachern P, et al. Evidence against the mucosal traction theory in cholesteatoma. Laryngoscope. 2018;128:1663-7
  11. Yamashita K, Yoshiura T, Hiwatashi A, et al. Contributing factors in the pathogenesis of acquired cholesteatoma: size analysis based on MDCT. AJR Am J Roentgenol 2011;196:1172-5
  12. Schilling V, Bujia J, Negri B, et al. Immunologically activated cells in aural cholesteatoma. Am J Otolaryngol 1991;12:249- 53
  13. Lampikoski H, Aarnisalo AA, Jero J, et al. Mastoid biofilm in chronic otitis media. Otol Neurotol 2012;33:785-8
  14. Yellon RF, Leonard G, Marucha PT, et al. Characterization of cytokines present in middle ear effusions. Laryngoscope 1991;101:165-9
  15. Louw L. Acquired cholesteatoma: summary of the cascade of molecular events. J Laryngol Otol 2013;127:542-9
  16. Tamhane UU,